Skip to main content
. 2021 Jul 9;7:31. doi: 10.1186/s40795-021-00438-y

Table 1.

Demographic, anthropometric and clinical characteristics of patients

Characteristic Total (n = 200)
Sex, no. (%)
 Male 118(59)
 Female 82(41)
 Age (years), mean (SD, range) 65(12.1, 20–89)
Education, no. (%)
 Illiterate 96(48)
 Primary 47(23)
 Secondary 30(15)
 Diploma 19(10)
 Academic 8(4)
Household size, no. (%)
 1 30(15)
 2 89(45)
 3 49(24)
 4 or more 32(16)
Socioeconomic status, no. (%)
 Low 85(42)
 Middle 95(48)
 High 20(10)
Smoking status, no. (%)
 Non-smoker 130(65)
 Former-smoker 48(24)
 Current smoker 22(11)
BMI category, no. (%)
 Under weight 2(1)
 Normal 66(33)
 Overweight 80(40)
 Obese 52(26)
 Weight loss in the last 6 months (yes), no. (%) 87(44)
 Waist circumference (cm), mean (SD) 95 (25)
 Supplement usea, no. (%) 46(23)
History of disease, no. (%)
 Heart disease 70(35)
 Diabetes 99(50)
 Hypertension 131(66)
 Hyperlipidemia 74(37)
 Heart failure duration (years), mean (SD, range) 2.6(3.6, 0.1–21)
 FBS (mg/dl), mean (SD) 146(67)
 TC (mg/dl), mean (SD) 142(47)
 TG (mg/dl), mean (SD) 112(61)
 HDL (mg/dl), mean (SD) 39(10)
 LDL (mg/dl), mean (SD) 80(39)
 Ejection fraction (%), mean (SD) 27(11.7)

SD indicated standard deviation, BMI body mass index, FBS fasting blood sugar, TC total cholesterol, TG triglyceride, HDL high density lipoprotein, LDL low density lipoprotein, BUN blood urea nitrogen, NA sodium, K potassium

aSupplement use was indicated as taking at least one of the Iron, Zinc, vitamin D, vitamin B groups, vitamin C and E supplementations